Abstract. Mutations in neuroblastoma amplified sequence (NBAS) cause infantile liver failure syndrome-2 (ILFS2). NBAS is a protein involved in Golgi-to-endoplasmic reticulum retrograde transport. Exon capture in combination with high-throughput sequencing was used to detect NBAS mutations. Via targeted sequencing, two causative mutations were identified from 358 selected genes associated with growth and development diseases; one was a missense mutation, c.3596G>A (p.C1199Y), detected in the coding region of NBAS (NM_015909.3), and the other a splice site mutation, c.209+1G>A. Both of these were heterozygous. The SEC39 structure of the wild-type NBAS protein was compared with a model of the mutated protein. The overall structure of the SEC39 after mutation did not change; however, steric hindrance did increase. In conclusion, two novel NBAS mutations were identified in a 4-year-old Chinese girl with ILFS2.
Introduction
Liver failure is a serious and common clinical syndrome induced in a number of different ways. With liver failure there is severe dysfunction or decompensation in liver synthesis, detoxification, excretion, and conversion. These are accompanied by coagulation disorders, jaundice, hepatic encephalopathy, ascites, and other clinical manifestations, that result in an extremely high mortality (1) . Acute and subacute forms of liver failure (ALF/SLF) are the most critical.
Infantile liver failure syndrome-2 (ILFS2, OMIM 616483) is an autosomal recessive genetic disorder connected with recurrent episodes of acute liver failure during intercurrent febrile illness. Initial episodes occur in infancy or early childhood, and with conservative treatment, full recovery is achieved between episodes. Haack et al identified homozygous or compound heterozygous mutations in the neuroblastoma amplified sequence (NBAS) gene in five unrelated German patients with ILFS2 (2) . NBAS was previously associated with short stature, optic nerve atrophy, and Pelger-Huet anomaly (SOPH syndrome, MIM614800) in an isolated Russian Yakut population, but without liver failure (3) . Further studies have found that the phenotypic spectrum of NBAS based diseases also involve brain, connective tissue, and the immune system (4, 5) . The NBAS protein is involved in Golgi-to-endoplasmic reticulum (ER) retrograde transport (6) and is considered to be a component of the SNAREs (Soluble N-Ethylmaleimide-sensitive Factor (NSF) Attachment Protein Receptors). Essentially every step of membrane transport is carried out by a pair of different SNARE proteins (v-SNARE and t-SNARE). The SNARE proteins mediate intracellular transport of vesicles, such as ER to Golgi and Golgi to plasma membranes, and are conserved from yeast to human. The NBAS protein interacts with t-SNARE p31 directly and with other proteins, forming complex syntaxin 18 (7) . In the cells of patients, a reduction in NBAS is accompanied by a decrease in p31, supporting an important function for NBAS in the SNARE complex (2) . Although these intracellular events are known, the specific mechanisms by which NBAS contributes to liver disease and to fever, is not fully understood.
In this study, we performed targeted next-generation sequencing (NGS) to identify mutations in 358 genes related to diseases of growth and development. The purpose of this was to devise a strategy useful for genetic diagnosis of patients with abnormal growth and development. By use of this strategy, two novel mutations in NBAS were identified in a 4-year-old Chinese girl with ILFS2. (8) .
Materials and methods

Study
NGS data analysis. After base calling by Illumina Pipeline, the primary data were obtained by fastq. Clean data for further analysis were obtained by filtering adapter and low quality reads (9) . To identify single nucleotide variants (SNVs) and indels, we aligned the 100 bp clean reads against the National Center for Biotechnology Information (NCBI) reference human genome sequence using Burrows-Wheeler Aligner software (10) . Indels and SNVs were identified using the GATK (Genome Analysis Toolkit) (11) . All SNVs were annotated using the dbSNP (http://www.ncbi.nlm.nih.gov/SNP/), HapMap (http://hapmap. ncbi.nlm.nih.gov/), HGMD (http://www.hgmd.org/), and the 1000 Genome (http://www.1000genomes.org/), respectively.
Sanger sequencing. Polymerase chain reaction (PCR) amplification was executed using primers specific for mutations of (15) . In order to check the energy stability of the mutants, the Web server I-Mutant 3.0 (http://gpcr2.biocomp. unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.cgi) was used (16) . The I-Mutant 3.0 suite is based on a support vector machine (SVM) algorithm that calculates protein stability related to a single mutation in units of free energy (ΔΔG).
Sequence conservative analysis and computer modeling.
Conservation across species indicates that a sequence has been maintained by evolution despite speciation. In this study, 
Results
Clinical status. The patient was a 4-year-old female with repeated upper respiratory tract infections that were associated with fever. There were no obvious physical abnormalities upon examination. Routine blood analysis showed a slightly elevated white blood cell count and a slightly elevated level of C-reactive protein (CRP). Liver function was abnormal: Alanine transaminase (ALT) 4,790 U/l, aspartate transaminase (AST) 7,690 U/l, alkaline phosphatase: 253 U/l; total bile acid: 267.5 µmol/l, blood glucose: 7.80 mmol/l, lactate dehydrogenase: 3,230 U/l; α-hydroxybutyrate dehydrogenase: 1,541 U/l, creatine kinase (CK) isoenzyme: 30.9 U/l, and CKMB/CK: 0.36. After anti-infection and liver-protection treatment (10% glucose 100 ml, reduced glutathione 0.45 i.v., 10% glucose 200 ml, and compound glycyrrhizin glucoside 40 mg, i.v. drip), symptoms mitigated and liver function normalized. After hospital discharge, the patient had repeated upper respiratory tract infections associated with fever and was readmitted to hospital for treatment. AST and ALT were abnormal for unknown reasons, even though there was no history of hepatitis. Determination clinical significance of genetic variants. All variants meeting the filtering criteria, described below, are listed in Table I . First, the allele frequency of variants should be less than 0.05 in the dbSNP, HapMap, 1,000 human genome dataset. Second, variants were considered as likely disease mutations, if sequence variation was previously reported and was a recognized cause of the disorder in dbSNP and HGMD. Third, variants were retained as disease mutations if they were predicted to result in a premature stop codon or loss of a substantial portion of the protein. Fourth, the variation was new, was forecasted to be harmful, and its allele frequency was less than 0.05. If these four criteria were met then the mutation was considered a disease mutation. In this study, the following NBAS SNVs were detected; c.6220G>A (p.A2074T), c.3596G>A (p.C1199Y), c.209+1G>A, c.1964A>G (P.K655R), and c.727A>G (p.I243V). Among them, although SIFT and PolyPhen-2 predicted that c.6220G>A was, respectively, harmful and potentially harmful, the frequency of the SNV in the three databases was 0.1821, 0.2434, and 0.1841 and was not studied further. In other words, this SNV appears to be common. In addition, c.1964A>G in the three databases was respectively, 0.497, 0.343, and 0.3397. The frequency of c.727A>G in the three databases was respectively, 0.4999, 0.333, and 0.3535. From this frequency information these two SNVs were also common in the population. Two uncommon SNVs were c.3596G>A and c.209 + 1G>A, which had no demonstrable allele frequency in the three databases. For c.3596G>A, SIFT's prediction was harmful and the I-Mutant 3.0 ΔΔG value was predicted to be -0.22 kcal/mol and SVM3 predicted a Large Decrease (Table II) . This information identified these two sites as potentially pathogenic.
Mutations analysis. Mutations c.3596G>A and c.209+1G>A were further confirmed by directional Sanger sequencing (Fig. 1) . We analyzed the mutation, c.209+1G>A, using the Human Splicing Finder program (http://umd.be/HSF3/index. html). Mutations found in this way alter the wild-type donor site, most likely affecting splicing. This heterozygous mutation was located at the splice donor site of intron 3, forming a new cleavage donor site that would result in the formation of frame shift mutations in the protein product and ultimately premature coding (Table II) . Such a truncated protein product would lose its normal function, resulting in disease (17) . The amino acid conservativeness of the c.3596G>A mutation was analyzed. NBAS was found to be conserved in human, chimpanzee, Rhesus monkey, dog, cattle, house mouse, chicken, tropical clawed frog, and zebrafish (Fig. 2) . The SEC39 region of the protein was found to be highly conserved. The SEC39 region is a necessary part of Golgi-ER retrograde transport, and the mutation was located in this evolutionary conserved region (Fig. 3) .
Computer modeling. In order to understand the effect of the c.3596G>A mutation on protein structure, a homology simulation for the SEC39 region was performed. The homology simulation was based on protein transport protein SEC39 (3k8p). Modeling and optimization was performed using YASARA software. Based on the protein model obtained by homology modeling, both cysteine and tyrosine were uncharged polar R-based amino acids, and on the whole, the model did not change (Fig. 4A) . The wild-type model appears more reasonable (Fig. 4B) in that the mutation model has a large amount of unreasonable steric hindrance. This conclusion implies that this mutation may lead to structural changes throughout the SEC39 region or the entire protein.
Discussion
Human genetic diseases typically occur in about 8% of the population (18) . Over the past decade, advances in technology have enabled the detection of all sequence changes in a single genome in a cost-effective manner. High throughput sequencing combined with capture techniques are increasingly used for routine diagnosis of Mendelian disease. Infantile liver failure is a rare but life-threatening disease. Mutations in NBAS are known causes of acute liver failure in children with fever. However, the physiological role of NBAS is not particularly clear.
In this study, we have identified two deleterious and rare variants by target NGS sequencing of 358 growth and development associated genes in a 4-year-old girl with ILFS2. Based on the child's medical history, clinical manifestations, laboratory examination, the young age of the patient, and an unknown etiology, hereditary liver disease was considered. However, the results here in show that by second-generation and Sanger sequencing NBAS mutations are the likely cause of the child's medical condition and that a diagnosis of ILFS2 is appropriate. One missense mutation c.3596G>A (p.C1199Y) and one splice site mutation c.209 + 1G>A were detected in the coding region of NBAS (NM_015909.3), both of which were heterozygotic. Missense mutations can lead to amino acid changes and may affect protein function while splice site mutations can cause intronic shear errors, which impact mRNA expression. The NBAS protein interacts with ZW10 and RINT1 at amino acid position 1,036 to 2,371, which supports the classification of the missense variant c.3596G>A as pathogenic (7, 19) .
This finding increases the number of NBAS mutations associated with the disease and will facilitate further studies of the syndrome. These results provide further insight into the molecular pathogenesis of the disease and identifies relationships among gene mutations and clinical manifestations of this syndrome.
